Search filters

List of works by Thierry André

5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens

scientific article published on 01 January 1993

A comparison of the effects of ursolic acid and l-leucine supplementation on IGF-1 receptor and AKT-mTOR signaling in response to resistance exercise in trained men.

scientific article published in December 2014

A continuous measure of fingertip friction during precision grip

scientific article published on 07 February 2009

A good cooperation between industry and French medical oncologists

scientific article published in February 2006

A network analysis of changes in molecular interactions in cellular signaling

scientific article published on 26 December 2006

A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial

scientific article

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

scientific article published on 01 April 1998

A type 2B von Hippel-Lindau family masquerading as a metastatic sporadic renal cell carcinoma

scientific article published on 01 March 2003

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer

scientific article

Actualités 2014 : le point de vue du comité de rédaction du Bulletin du Cancer

scholarly article by Christophe Massard et al published January 2015 in Bulletin du Cancer

Adenocarcinoma of the pancreas. Therapeutic strategies

scientific article published on 01 March 1998

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

scientific article published on 2 November 2015

Adjuvant therapy for stage II and III colorectal cancer

scientific article published on 01 April 2007

Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuva

scientific article published on 20 August 2012

Aflibercept (Zaltrap(®)) approved in metastatic colorectal cancer

scientific article

American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view

scientific article

American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view

scientific article

An overview of adjuvant systemic chemotherapy for colon cancer.

scientific article published on June 2004

Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

scientific article published on 4 September 2015

Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies ⬇️

scientific article published on August 6, 2012

Anti-angiogenic treatments in metastatic colorectal cancer: Does a continuous angiogenic blockade make sense?

scientific article

Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma

scientific article published on October 2015

Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK).

scientific article published on 30 December 2017

Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: Is efficacy an impact of toxicity?

scientific article

BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?

scientific article published on February 2017

BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer

scientific article published on 11 February 2020

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

scientific article

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

scientific article published on 22 October 2015

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

scientific article published on 01 March 1997

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.

scientific article

CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR

scientific article published on 01 September 1999

Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: Post hoc Analysis of the MOSAIC and PETACC-8 Trials

scientific article published on 01 July 2019

Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer.

scientific article published on 8 April 2008

Cetuximab efficacy in patients treated routinely in university hospitals

scientific article published in November 2007

Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms

scientific article published on 08 March 2018

Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.

scientific article

Colon cancer

scientific article published on 01 September 2006

Colon cancer: what is new in 2004?

scientific article published in January 2004

Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial.

scientific article published on 22 January 2018

Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status.

scientific article

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer

scientific article published on 5 February 2018

Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).

scientific article published in April 2010

Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinair

scientific article

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

scientific article published on 22 June 2018

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

scientific article

Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma

scientific article published on 29 February 2012

Current status of adjuvant therapy for colon cancer.

scientific article published on May 2007

Cutaneous adverse reactions of EGFR (epidermal growth factor receptor)-inhibitors: therapeutic algorithm of the French PROCUR group

scientific article published in May 2013

Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database

scientific article published on 8 February 2016

Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colon

scientific article published on 01 September 1997

Disseminated and circulating tumor cells in gastrointestinal oncology

scientific article published on 01 May 2012

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).

scientific article published on 25 August 2017

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer

scientific article

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

scientific article published on 01 March 2018

EGFR in colorectal cancer: more than a simple receptor

scientific article published on 08 March 2006

EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies.

scientific article

Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study

scientific article published on 19 October 2015

Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer.

scientific article published on 26 February 2008

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.

scientific article published on May 2016

Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies

scientific article published on 08 March 2018

Effect of skin hydration on the dynamics of fingertip gripping contact.

scientific article

Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective study.

scientific article

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study.

scientific article published on 19 January 2009

Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.

scientific article published on 22 June 2016

Electron and photon diagnostics for plasma acceleration-based FELs.

scientific article published in January 2018

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

scientific article published on 25 July 2016

FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients

scientific article

FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.

scientific article published on 22 May 2009

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, rando

scientific article published on 17 November 2014

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, rando

scientific article published on 01 May 2015

Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

scientific article published on 2 December 2015

Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer.

scientific article

Fingertip moisture is optimally modulated during object manipulation

scientific article published on 11 November 2009

Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review ⬇️

scientific article published on March 16, 2012

Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer

scientific article published on December 2010

Frequent intragenic rearrangements of DPYD in colorectal tumours

article

From Chemotherapy to Targeted Therapy in Adjuvant Treatment for Stage III Colon Cancer ⬇️

scientific article published on August 1, 2011

Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer

scientific article published on 01 October 2016

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

scientific article

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.

scientific article

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

scientific article

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study

scientific article

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

scientific article

Gemcitabine-based combinations in inoperable pancreatic cancers

scientific article

Genetic control of plasticity of oil yield for combined abiotic stresses using a joint approach of crop modeling and genome-wide association.

scientific article

HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer

scientific article published on 01 February 2016

Hepatotoxicity of metastatic colorectal cancer chemotherapy: systematic review

scientific article published in May 2010

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).

scientific article

High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors

scientific article published in April 1996

Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer

scientific article published on 18 December 2017

Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy

scientific article

Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells

scientific article published on 24 October 2014

Immune response and digestive cancers: Prognostic and therapeutic implications

scientific article published on 19 January 2017

Immunotherapy for Early Stage Colorectal Cancer: A Glance into the Future

scientific article published on 21 July 2020

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

scientific article published on 01 January 2007

Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study

scientific article published on 05 July 2018

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.

scientific article

Impact of preoperative and postoperative FOLFOX chemotherapies in patients with resectable colorectal liver metastasis

scientific article published on 01 September 2014

In Vitro Antagonistic Activity Evaluation of Lactic Acid Bacteria (LAB) Combined with Cellulase Enzyme Against Campylobacter jejuni Growth in Co-Culture ⬇️

scientific article published on January 1, 2011

Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.

scientific article published on 3 November 2009

Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -inde

scientific article published on August 2005

Intensification thérapeutique et autotransplantation de cellules-souches hématopoïétiques dans le traitement des tumeurs solides de l'adulte. Principes, réalisation et application au traitement des tumeurs germinales, trophoblastiques, mammaires

scientific article published on 01 January 1995

Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study

scientific article

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

scientific article

Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma

scientific article published on 13 June 2012

Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments

scientific article published on 03 May 2018

L’année 2015 à travers le regard du comité de rédaction du Bulletin du cancer

scholarly article by Nicolas Magné et al published January 2016 in Bulletin du Cancer

MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study

scientific article published on 13 January 2017

Malignant biliary obstruction, general review and clinical practice

scientific article published on May 1, 2013

Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.

scientific article published on 27 April 2012

Microangiopathic hemolytic anemia associated with uterine sarcoma: report of a case. Review of the literature

scientific article published in January 1996

Moisture Evaluator: a direct measure of fingertip skin hydration during object manipulation.

scientific article published in November 2008

Molecular Targets for the Treatment of Metastatic Colorectal Cancer

scientific article published on 20 August 2020

Molecular analysis of sentinel lymph node in colon carcinomas by one-step nucleic acid amplification (OSNA) reduces time to adjuvant chemotherapy interval.

scientific article published on 30 May 2017

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study

scientific article

Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.

scientific article

Nab-paclitaxel

scientific article published on 23 May 2015

Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial

scientific article

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.

scientific article published on 19 July 2017

Observational Cohort Study of Patients With Metastatic Colorectal Cancer Initiating Chemotherapy in Combination With Bevacizumab (CONCERT).

scientific article published on 9 August 2016

Observational study on conditions for access to the analysis of KRAS mutation in patients with metastatic colorectal cancer receiving panitumumab treatment

scientific article

Operable colon cancer: initial strategy

scientific article published on October 20, 2010

Osteonecrosis of the hip in renal transplant recipients. Changes in functional status and magnetic resonance imaging findings over three years in three hundred five patients

scientific article published on 01 June 1996

Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program.

scientific article

Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer.

scientific article

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

scientific article

Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer. The GERCOD

scientific article

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer

scientific article published on 24 January 2016

PET and digestive cancers

scientific article published on 22 October 2007

PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial.

scientific article published on 2 December 2015

Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study.

scientific article published on 05 October 2012

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study

scientific article published on 13 August 2014

Peptide microarrays for the detection of molecular interactions in cellular signal transduction

scientific article

Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer.

scientific article

Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.

scientific article

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

scientific article

Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma

scientific article published in February 1996

Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer

scientific article published on 01 June 2011

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

scientific article

Platinum-sensitivity in metastatic colorectal cancer: towards a definition.

scientific article published on 3 September 2013

Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†.

scientific article published on 3 March 2015

Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas

scientific article published on 17 November 2017

Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.

scientific article published on 25 April 2017

Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAF(V600E) in Patients with Lymph Node-Positive Colon Cancer

scientific article

Prognostic factor analysis in advanced gastric cancer patients treated with hydroxyurea, leucovorin, 5-fluorouracil, and cisplatin (HLFP regimen).

scientific article published in January 2003

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP).

scientific article published on 12 July 2016

Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort

scientific article published on 24 January 2015

Prognostic value and characteristics of N1c colorectal cancer

scientific article published on 30 June 2018

Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestiv

scientific article

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study

scientific article published on 01 November 2020

Randomized Phase 3 Study of Panitumumab With FOLFIRI vs. FOLFIRI Alone as Second-Line Treatment in Patients With Metastatic Colorectal Cancer.

scientific article

Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies

scientific article

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

scientific article

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

scientific article

Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR study.

scientific article published in April 2013

Rectal cancer and adjuvant chemotherapy: which conclusions?

scientific article published in January 2010

Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).

scientific article

Reintroduction of Oxaliplatin Is Associated With Improved Survival in Advanced Colorectal Cancer

scientific article published on 01 August 2007

Reply to M. Gallén et al and R.S. Midgley et al.

scientific article published in April 2013

Reply to the Letter by S. Sorscher Regarding "Implications of BRAF Mutations in dMMR Colorectal Cancers".

scientific article published on 18 September 2017

Respiratory muscle weakness in acute heart failure patients.

scientific article published on 22 June 2011

S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.

scientific article published on 28 May 2013

Safety Analysis of FOLFOX4 Treatment in Colorectal Cancer Patients: A Comparison Between Two Asian Studies and Four Western Studies ⬇️

scientific article published on November 17, 2011

Self-expandable metallic stent for palliative treatment of colorectal malignant obstructions: risk of perforation

scientific article published on 01 July 2003

Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.

scientific article published in August 2003

Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma

scientific article published on 31 December 2014

Stage III Colon Cancer: What Works, What Doesn't and Why, and What's Next

scientific article published on 01 January 2012

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Adminis

scientific article published on 01 November 2003

Survey on the management of skin toxicity associated with EGFR inhibitors amongst French physicians.

scientific article published on 3 January 2012

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

scientific article

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBACCA) nested within a compassionate use program

scientific article

Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma

scientific article published on 01 June 1996

Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.

scientific article published on December 2010

The Evolution of Adjuvant Therapy in the Treatment of Early-Stage Colon Cancer ⬇️

scientific article published on December 1, 2011

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 [...]

scientific article (publication date: 2013)

The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.

scientific article

The hard road to data interpretation: three or six months of adjuvant chemotherapy for patients with stage III colon cancer?

scientific article published on 9 February 2018

Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system

scientific article published on 6 August 2016

Therapeutic strategy in unresectable metastatic colorectal cancer.

scientific article published on March 2012

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial

scientific article published on 05 April 2018

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial

scientific article

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

scientific article published on January 2007

Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002)

scientific article

Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database

scientific article published on 25 July 2016

Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa

scientific article published on 01 April 2000

[36th Congress of the American Society of Clinical Oncology (ASCO). New Orleans 20-23 May 2000]

scientific article published on 01 August 2000

[Adenocarcinoma of the pancreas. Diagnosis and evaluation]

scientific article published on 01 March 1998

[Adenocarcinoma of the pancreas. General characteristics]

scientific article published on 01 March 1998

[Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006]

scientific article published on 01 January 2007

[Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?]

scientific article published on 01 June 2012

[Adjuvant treatment of colorectal cancer]

scientific article published on 01 July 2006

[Anti-angiogenic treatment and colorectal cancer]

scientific article published on 01 July 2007

[Anticancer chemotherapy in the elderly: a review of the literature]

scientific article published on 01 May 2008

[Anticancer drugs off label used of: what do the experts think about?]

scientific article published on 01 October 2004

[Anticancer drugs use evaluation: limits of the approved labeling]

scientific article published on 01 May 2004

[Chemotherapy of colorectal cancers with metastases]

scientific article published on 01 November 1996

[Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas]

scientific article published on 01 December 1999

[Commitment of The Bulletin du Cancer and the Collège national des enseignants en cancérologie (CNEC) to publish quality papers from residents' thesis]

scientific article published in March 2016

[Congress of the American Society of Clinical Oncology]

scientific article published on 01 October 2002

[Cyclo-oxygenase 2 inhibitors and cancer]

scientific article published on 01 May 2004

[Cyclo-oxygenase 2 inhibitors and cancer]

[Fluoropyrimidines cardiac toxicity: 5-fluorouracil, capecitabine, compound S-1 and trifluridine/tipiracil]

scientific article published on 28 June 2018

[Gemcitabine and digestive carcinomas]

scientific article published on 01 January 2007

[HER2 and gastric cancer. Recommendations for clinical practice in 2011].

scientific article

[IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients!]

scientific article published on 01 June 2018

[Is it necessary to perform a surgery after neo-adjuvant treatment for initially borderline or locally advanced pancreatic adenocarcinoma?]

scientific article published on 01 June 2015

[Major advances in Oncology in 2013: the editorial board of the Bulletin du Cancer point of view]

scientific article published on 01 January 2014

[Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)]

scientific article published on 01 January 1997

[Mulleroblastoma of the uterus. Role of chemotherapy. A case report]

scientific article published on 01 January 1996

[New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].

scientific article

[Regorafenib approved in Metastatic Colorectal cancer]

scientific article published on 01 October 2013

[Référentiel de bon usage and Thésaurus national de cancérologie digestive: analysis of non-conform prescriptions in Tenon hospital]

scientific article published on 01 February 2009

[Should cases of hepatocellular carcinoma be discussed by non-specialized multidisciplinary team meetings?]

scientific article published on 01 June 2014

[Targeted therapies in oncology: an ambiguous terminology]

scientific article published on 17 September 2008

[Therapeutic intensification and autotransplantation of hematopoietic stem cells in metastatic breast cancers]

scientific article published on 01 November 1996

[Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults: principles, realization and application to the treatment of germ cell, trophoblastic, breast, ovarian and small-cell bronchial t

scientific article published in January 1995

[Tumoral angiogenesis: physiopathology, prognostic value and therapeutic perspectives].

scientific article published in December 1998

[Undifferentiated embryonal sarcoma in the liver of adults]

scientific article published on 01 March 1998

[What changes were made in the National Thesaurus of Gastrointestinal Cancer in 2005?]

scientific article published on 01 October 2006

[Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board]

scientific article published on 19 December 2016

Paulina is supported by:

About Paulina

Help